SPIN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.170200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.761200E-01
Normal-vs-Stage2
3.799400E-01
Normal-vs-Stage3
1.516580E-01
Normal-vs-Stage4
7.100600E-01
Stage1-vs-Stage2
6.275000E-01
Stage1-vs-Stage3
1.315550E-02
Stage1-vs-Stage4
2.291800E-01
Stage2-vs-Stage3
6.226200E-02
Stage2-vs-Stage4
6.356400E-02
Stage3-vs-Stage4
2.903900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.863600E-01
Normal-vs-AfricanAmerican
7.734200E-01
Normal-vs-Asian
3.725000E-01
Caucasian-vs-AfricanAmerican
5.894400E-01
Caucasian-vs-Asian
3.860200E-01
AfricanAmerican-vs-Asian
4.244800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.555200E-01
Normal-vs-Female
3.968000E-01
Male-vs-Female
9.726200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.605800E-01
Normal-vs-Age(41-60Yrs)
8.946600E-01
Normal-vs-Age(61-80Yrs)
2.916800E-01
Normal-vs-Age(81-100Yrs)
4.776000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.680000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.774400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.005200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.826000E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.639200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.396600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.568990E-01
Normal-vs-Daily Drinker
2.403800E-01
Normal-vs-Weekly Drinker
3.917600E-01
Normal-vs-Occasional Drinker
8.202400E-01
Normal-vs-Social Drinker
8.928800E-01
Non Drinker-vs-Daily Drinker
7.303000E-01
Non Drinker-vs-Weekly Drinker
3.845000E-01
Non Drinker-vs-Occasional Drinker
3.808400E-02
Non Drinker-vs-Social Drinker
1.870040E-02
Daily Drinker-vs-Weekly Drinker
6.005400E-01
Daily Drinker-vs-Occasional Drinker
1.031440E-01
Daily Drinker-vs-Social Drinker
5.742200E-02
Weekly Drinker-vs-Occasional Drinker
3.143400E-01
Weekly Drinker-vs-Social Drinker
2.037000E-01
Occasional Drinker-vs-Social Drinker
8.391600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.340750E-01
Normal-vs-Grade 2
2.463800E-02
Normal-vs-Grade 3
4.689500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.530190E-01
Grade 1-vs-Grade 3
2.754600E-01
Grade 1-vs-Grade 4
1.340750E-01
Grade 2-vs-Grade 3
8.836600E-01
Grade 2-vs-Grade 4
2.463800E-02
Grade 3-vs-Grade 4
4.689500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.694000E-01
Normal-vs-NonDiabetic
3.967600E-01
Diabetic-vs-NonDiabetic
2.967200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.931800E-01
Normal-vs-NoPancreatitis
3.739200E-01
Pancreatitis-vs-NoPancreatitis
7.786200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.747800E-01
Normal-vs-N1
4.145800E-01
N0-vs-N1
8.175600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.013800E-01
Normal-vs-TP53-NonMutant
4.926200E-01
TP53-Mutant-vs-TP53-NonMutant
3.247600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
